Cavalcante, Marcela Frota; Kazuma, Soraya Megumi; Bender, Eduardo André; Adorne, Márcia Duarte; Ullian, Mayara; Veras, Mariana Matera; Saldiva, Paulo Hilário Nascimento 
; Maranhão, Andréa Queiroz; Guterres, Sílvia Stanisçuaski; Pohlmann, Adriana Raffin; Abdalla, Dulcinéia Saes Parra
Source: European Journal of Pharmaceutics and Biopharmaceutics. Unidades: FM, FCF
Subjects: ARTERIOSCLEROSE, MACRÓFAGOS, NANOTECNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAVALCANTE, Marcela Frota et al. A nanoformulation containing a scFv reactive to electronegative LDL inhibits atherosclerosis in LDL receptor knockout mice. European Journal of Pharmaceutics and Biopharmaceutics, v. 107, p. 120-129, 2016Tradução . . Disponível em: https://doi.org/10.1016/j.ejpb.2016.07.002. Acesso em: 18 nov. 2024.APA
Cavalcante, M. F., Kazuma, S. M., Bender, E. A., Adorne, M. D., Ullian, M., Veras, M. M., et al. (2016). A nanoformulation containing a scFv reactive to electronegative LDL inhibits atherosclerosis in LDL receptor knockout mice. European Journal of Pharmaceutics and Biopharmaceutics, 107, 120-129. doi:10.1016/j.ejpb.2016.07.002NLM
Cavalcante MF, Kazuma SM, Bender EA, Adorne MD, Ullian M, Veras MM, Saldiva PHN, Maranhão AQ, Guterres SS, Pohlmann AR, Abdalla DSP. A nanoformulation containing a scFv reactive to electronegative LDL inhibits atherosclerosis in LDL receptor knockout mice [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2016 ; 107 120-129.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.ejpb.2016.07.002Vancouver
Cavalcante MF, Kazuma SM, Bender EA, Adorne MD, Ullian M, Veras MM, Saldiva PHN, Maranhão AQ, Guterres SS, Pohlmann AR, Abdalla DSP. A nanoformulation containing a scFv reactive to electronegative LDL inhibits atherosclerosis in LDL receptor knockout mice [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2016 ; 107 120-129.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.ejpb.2016.07.002
